Cochlear | COH - 债务

金融业

AUD

AUD 2.79B

现金及等价物

AUD 275.7M

AUD 319.2M

AUD 1.37B

AUD 558.9M

AUD 235.7M

股息收益率

1.17

AUD 261.1M

AUD 306.4M

5.5K

EPS每股收益

AUD 3.13

股本和储备

AUD 1.94B

AUD 856.8M

债务利息支出

AUD 6.3M

AUD 7.4M

AUD 200M

AUD 7.3B

AUD 161.5M

AUD 914.9M

AUD 261.1M

普通股股本

AUD 65.4M

43.67

AUD 121.1M

AUD 1.18B

销售和管理费用

AUD 449.4M

AUD 499.4M

贸易债权人

AUD 281.3M

应收帐款人

AUD 568.4M

	债务	更改		日
Ansell	USD 805.6M		51.6M	2025-06
Avita Medical	AUD 46.05M		1.46M	2025-12
Cochlear	AUD 235.7M		10.9M	2025-06
CSL	USD 11.96B		219M	2024-12
Healius	AUD 1.4B		199.1M	2024-12
Integral Diagnostics	AUD 357.8M		3.7M	2024-06
Mayne Pharma	AUD 38.82M		2.24M	2024-06
Mesoblast	USD 135.14M		6.99M	2025-12
Monash IVF	AUD 159.39M		24.02M	2024-12
Nanosonics	AUD 7.69M		1.49M	2025-06
Polynovo	AUD 15.38M		49K	2024-06
Ramsay Health Care	AUD 12.12B		864.4M	2025-06
Regis Healthcare	AUD 5.11M		807K	2025-06
ResMed	USD 843.17M		3.18M	2026-03
Sigma Healthcare	AUD 137.64M		1.01M	2024-07
Somnomed	AUD 23.51M		534.68K	2023-06
Sonic Healthcare	AUD 4.8B		282.9M	2024-12
Telix Pharmaceuticals	AUD 418.25M		163.2M	2025-06